AgeTech Ventures
Subscribe
Sign in
Home
Market Maps
Science
Thematic Musings
Policy
Archive
About
#6: The Tale of AgeTech Unicorns
A closer look at AgeTech unicorns today and the white spaces they leave behind.
Apr 6
•
Jenny Xie
Share this post
AgeTech Ventures
#6: The Tale of AgeTech Unicorns
Copy link
Facebook
Email
Notes
More
February 2025
#5 Medicare Part II: How it's working
In this post, we walk through the data and research on Medicare and Medicare Advantage so you can better understand the context behind the ongoing…
Feb 28
•
Jenny Xie
1
Share this post
AgeTech Ventures
#5 Medicare Part II: How it's working
Copy link
Facebook
Email
Notes
More
#4 Medicare Part I: How it works
Medicare and Medicare Advantage: it's complicated! Here's a quick guide to the key mechanics of the program.
Feb 3
•
Jenny Xie
5
Share this post
AgeTech Ventures
#4 Medicare Part I: How it works
Copy link
Facebook
Email
Notes
More
1
December 2024
#3: Longevity 101
The basics of the medical field dedicated to keeping us healthier for longer.
Dec 1, 2024
•
Jenny Xie
3
Share this post
AgeTech Ventures
#3: Longevity 101
Copy link
Facebook
Email
Notes
More
September 2024
#2 What is AgeTech?
How do we define AgeTech as a category of innovation, company formation and investment? Here I propose a framing based on the different value props that…
Sep 1, 2024
•
Jenny Xie
3
Share this post
AgeTech Ventures
#2 What is AgeTech?
Copy link
Facebook
Email
Notes
More
August 2024
#1: Personal Mobility Market Map
First post on AgeTech Ventures! Here we walk through the exciting companies that are pushing the boundaries in tackling personal mobility for older…
Aug 16, 2024
•
Jenny Xie
2
Share this post
AgeTech Ventures
#1: Personal Mobility Market Map
Copy link
Facebook
Email
Notes
More
July 2024
AgeTech Ventures
Welcome to AgeTech Ventures! I'm a VC who loves diving into all things AgeTech and sharing my thoughts on different topics in this space.
Jul 20, 2024
•
Jenny Xie
2
Share this post
AgeTech Ventures
AgeTech Ventures
Copy link
Facebook
Email
Notes
More
2
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts